News/ News/ R&D Catabasis craters after giving up on muscular dystrophy lead Phil Taylor Catabasis, Duchenne muscular dystrophy, edasalonexent, genetic diseases 0 Comment Catabasis has conceded defeat with its Duchenne muscular dystrophy drug edasalonexent, pulling the plug on the drug after Share X Catabasis craters after giving up on muscular dystrophy lead https://pharmaphorum.com/news/catabasis-craters-after-giving-up-on-muscular-dystrophy-lead/